October 6, 2014
HIV R4P is the world's first and only scientific meeting dedicated exclusively to biomedical HIV prevention research and it's happening October 28-30, 2014 in Cape Town, South Africa.   CONRAD is a sponsor of the conference and our scientists will be making a number of presentations, as well as hosting a pre-conference satellite session with AVAC on Monday, October 27th from 1:30-5:00pm – “The Road to Adherence: Lessons Learned, Barriers and Drivers, Innovative Solutions.  Click on the attachment below to view the full agenda.

Our presenters and presentations include:

Meredith Clark, PhD – CONRAD Manager, Drug Delivery

Tuesday, October 28th - 11:15am – Oral abstract: “Tenofovir Reservoir Intravaginal Rings Provide Superior Pharmacokinetics and Higher Sustained Drug Levels than Tenofovir Matrix Rings”

Wednesday, October 29th - 10:00am and 5:00pm - Poster presentation: “Overcoming Phase Behavior and Surface Crystallization in a Tenofovir-levonorgestrel Intravaginal Ring”

Gustavo Doncel, Ph.D, MD - CONRAD and Executive Director 

Wednesday, October 29th - 1:30-5:00pm - Chair, Oral Abstract Session: Evaluation of Novel Biomedical Interventions 

Jill Schwartz, MD - CONRAD Medical Director

Wednesday, October 29th - 11:30am – Oral abstract: “Multicompartmental Pharmacokinetics of Tenofovir 1% Gel Using the BAT 24 Regimen Versus Daily and Single Pericoital Dosing”

4:15pm – “Novel On-Demand Vaginal Microbicide Formulations: Tablets and Films”

Andrea Thurman, MD - EVMS Associate Professor of OBGYN

Tuesday, October 28th -  2:30pm - Oral abstract: “Effect of Bacterial Vaginosis on Markers of Genital Tract Inflammation and Mucosal Immunity: Mechanisms for Susceptibility to HIV infection:  

Wednesday, October 29th - 10:00am and 5:00pm - Poster presentation: “Assessment of the Vaginal Residence Time of Biomarkers of Semen Exposure”

Thursday, October 30th - 10:00am and 5:00pm - Poster presentation: “Mucosal Susceptibility to HIV-1 and Tenofovir Protection in Explanted Cervicovaginal Tissues from Postmenopausal compared to Premenopausal Women”

Irina Zalenskaya, PhD - EVMS Assistant Professor

Thursday, October 30th - 10:00am and 5:00pm – Poster presentation: “Gene Expression Analysis of Human Vaginal Mucosal Response to Pro-inflammatory Stimuli - Identification of Biomarkers of Vaginal Inflammation”

Additional presentations with CONRAD contributors:

Wednesday, October 29th - 11:45 - 12:00:  Population Pharmacokinetic Model of Vaginal Tenofovir 1% Gel in the Cervicovaginal Fluid - Kuo-Hsiung Yang1, Jill L. Schwartz2, Craig Sykes1, Gustavo F. Doncel2, Angela D.M. Kashuba1 

Thursday, October 30th - 5:25 - 5:35: "He Said, She Said." Exploring Couples' Sensory Perceptions and Experiences with Vaginal Gels & Film: Implications for Microbicide Development - Kathleen M. Morrow1, Rochelle K. Rosen2, Joseph L. Fava3, Lisa Rohan4, Erna M. Kojic5, David Friend6, David Katz7, Robert Buckheit8


Wednesday, 29 October: Biomarkers of Cervical Inflammation and Immunity Associated with Cervical HIV-1 RNA - Presenter: Raina Fichorova, CONRAD contributors: Christine Mauck and Andrea Thurman

Wednesday, 29 October: MZC and 1% TFV Gel: Multipurpose Prevention Approaches, Presenter: José Fernández-Romero, CONRAD Contributors: Meredith Clark and Gustavo Doncel

Thursday, 30 October: Endosymbiont Trichomonas Vaginalis Virus as a Target for HIV Prevention - Presenter: Raina Fichorova, CONRAD Contributors: Meredith Clark and Gustavo Doncel
Thursday, 30 October: Tenofovir Gel Acceptability and Adherence among Pregnant Women in the United States - Presenter: Elizabeth Montgomery, CONRAD contributor: Jill Schwartz

Thursday, 30 October:  Obstetric and Infant Outcomes Following Planned Maternal Third Trimester Exposure to Tenofovir 1% Vaginal Gel - Presenter: Lisa Noguchi, CONRAD contributor: Jill Schwartz


For more information on the conference, go to


Additional Documents

1911 North Fort Myer Drive, Suite 900, Arlington, Virginia 22209   T: (703) 524-4744 |